The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.
about
A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomesThe cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Costs and cost-effectiveness of training traditional birth attendants to reduce neonatal mortality in the Lufwanyama Neonatal Survival study (LUNESP).Individual-based simulation models of HIV transmission: reporting quality and recommendations.Adherence with drug therapy in pregnancyPrevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and ResearchAcceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study.Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.Cost-effectiveness of adherence interventions for highly active antiretroviral therapy: a systematic review.Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.Cost-effectiveness of adherence-enhancing interventions: a systematic review.What we know and what we do not know about factors associated with and interventions to promote antiretroviral adherence.Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.Successful prevention of perinatal HIV transmission utilizing direct observation therapy in the setting of Acquired Immunodeficiency Syndrome (AIDS) and progressive multifocal leukoencephalopathy
P2860
Q26796419-04D71E6F-B802-497C-80FB-68D2283B66A3Q33940190-A3E8BA45-D80F-4F7A-8487-CA54ED2EFFB8Q34251156-CD63B7EA-41A4-4DD0-8BBE-E7A00A8257D1Q35010032-832A6F75-6262-437C-8259-2BC053EDEE72Q35660022-F678D840-75B4-455D-A98E-88FAE8D5ECB4Q36616443-44FFAC80-7CC2-4606-A4A6-79F5B3510F98Q36861872-A3991A40-1751-4CC1-8C8B-81BBAD30C591Q37335159-601A493A-B13F-4E50-832C-30BF0D03C927Q38113885-380EDC11-BF5B-4D35-ACFC-81CAAAF4E224Q38114141-15A98FF6-FDEC-42BD-B02B-D466ABAFB575Q38687403-9B4A3EAB-6345-4A00-8709-4BBE73916D42Q41345903-1D6C69B9-6FB9-4736-81A3-FA316FAC8171Q42252019-4C9BF14C-A360-4B08-A353-B168712CE8EBQ47549891-C3FC9E45-FAE3-4653-8053-D6BBB7C12B7CQ54219902-B5DEDEA2-B55A-43FF-B663-E788D6042513Q58762636-E9776F54-45A0-46F6-B09D-BD8CEDAA85B5
P2860
The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@ast
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@nl
type
label
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@ast
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@nl
prefLabel
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@ast
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@nl
P2860
P1433
P1476
The cost-effectiveness of dire ...... n HIV-infected pregnant women.
@en
P2093
Caitlin J McCabe
David N Fisman
P2860
P304
P356
10.1371/JOURNAL.PONE.0010154
P407
P50
P577
2010-04-13T00:00:00Z